Results 1 to 10 of about 5,641 (130)

aMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure [PDF]

International Journal of General Medicine, 2022
Yunqing Sun,* Zhuohong Li,* Guichan Liao, Muye Xia, Xuwen Xu, Shaohang Cai, Jie Peng Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, People’s Republic of China*These authors ...
Sun Y, Li Z, Liao G, Xia M, Xu X, Cai S, Peng J   +6 more
doaj   +5 more sources

Clinical Utility of the aMAP Score for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B [PDF]

Diagnostics
This study aimed to evaluate the efficacy of the aMAP score and compare it with other risk scores for predicting hepatocellular carcinoma (HCC) development in Thai patients with chronic hepatitis B (CHB).
Supakorn Chaiwiriyawong, Suraphon Assawasuwannakit, Poorikorn Feuangwattana, Pimsiri Sripongpun, Naichaya Chamroonkul, Teerha Piratvisuth, Apichat Kaewdech   +6 more
doaj   +4 more sources

The Age-Male-Albumin-Bilirubin-Platelets (aMAP) Risk Score Predicts Liver Metastasis Following Surgery for Breast Cancer in Chinese Population: A Retrospective Study [PDF]

ImmunoTargets and Therapy
Li Chen,1,2,* Qiang Liu,2,* Chunlei Tan,3,* Tiangen Wu,4,* Meng Wu,5 Xiaosheng Tan,5 Jinwen Liu,1 Jing Wang2 1Department of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,
Chen L, Liu Q, Tan C, Wu T, Wu M, Tan X, Liu J, Wang J   +7 more
doaj   +4 more sources

External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy [PDF]

Frontiers in Medicine, 2021
Background and Aim: A prediction model of hepatocellular carcinoma (HCC) risk in patients with chronic liver diseases, based on age, male sex, albumin-bilirubin, and platelets (aMAP), has been previously reported. We validated the aMAP score and compared
Honglian Gui, Yan Huang, Gangde Zhao, Lichang Chen, Wei Cai, Hui Wang, Qing Guo, Qing Xie   +7 more
doaj   +3 more sources

Impact of cardiometabolic risk factors on hepatocellular carcinoma incidence in patients with chronic hepatitis B: A retrospective cohort study. [PDF]

PLoS ONE
Background and aimsChronic hepatitis B virus (HBV) infection remains a major global health burden and a leading cause of hepatocellular carcinoma (HCC).
Chanavee Toh, Kedsiree Sanit, Pimsiri Sripongpun, Naichaya Chamroonkul, Suthat Liangpunsakul, Teerha Piratvisuth, Apichat Kaewdech   +6 more
doaj   +2 more sources

A stratified precision screening strategy for enhancing hepatitis B- and C-associated liver cancer detection: a prospective study [PDF]

Scientific Reports
This study explores new screening strategies to enhance liver cancer screening effectiveness. In a prospective study, 2605 participants underwent baseline, 6-months self-reported, and 1-year follow-up screenings using abdominal ultrasonography, AFP, AFP ...
Hua He, Yanhua Wu, Zhifang Jia, Yangyu Zhang, Yuchen Pan, Yuzheng Zhang, Kaisheng Su, Yingnan Cui, Yuanlin Sun, Dongming Li, Haiyong Lv, Jiaxin Yi, Yuehui Wang, Changgui Kou, Xiaofeng Sun, Jing Jiang   +15 more
doaj   +2 more sources

HCC risk stratification scores: insights from large multi-center national cohort study [PDF]

Scientific Reports
Current guidelines advocate biannual HCC surveillance for chronic hepatitis C patients who achieved sustained virological response (SVR) following direct acting antivirals (DAAs), posing a heavy burden on healthcare systems.
Imam Waked, Gamal Esmat, Mohamed Abdallah, Aisha Elsharkawy, Wafaa Elakel, Islam Ammar, Ehab Kamal, Mohamed Hassany, Nabiel Mikhail, Riham Soliman, Wahid Doss, Gamal Shiha   +11 more
doaj   +2 more sources

Prediction of Hepatocellular Carcinoma in a Portuguese Population after Hepatitis C Cure: Comparative Accuracy of Noninvasive Tests (Transient Elastography, FIB-4, and aMAP) [PDF]

GE: Portuguese Journal of Gastroenterology
Introduction: Chronic infection with hepatitis C virus (HCV) causes 25% of hepatocellular carcinoma (HCC) cases worldwide, a major cause of morbimortality even after sustained virologic response (SVR).
André Mascarenhas, Juliana Serrazina, Sérgio Bronze, Helena Cortez-Pinto, José Presa, Ana Barreira, Paulo Carrola, Francisco Vara-Luiz, Alexandra Rosu-Pires, Pedro Lages Martins, Rita Prata, Joana Revés, Catarina Bravo, Catarina Nascimento, Catarina Gouveia, Ana Rita Franco, Pedro Lima, Catarina O’Neill, Raquel R. Mendes, Inês Rodrigues Simão, Inês Costa Santos, André Ruge Gonçalves, Pedro Barreiro, Rui Mendo, Rita Barosa, Pedro Figueiredo, Cristina Chagas   +26 more
doaj   +2 more sources

Study on SARS-CoV-2 infection in middle-aged and elderly population infected with hepatitis virus: a cohort study in a rural area of northeast China [PDF]

PeerJ
Background To investigate the symptoms, the level of antibody, the progression of liver disease after SARS-CoV-2 infection in middle-aged and elderly population infected with hepatitis virus.
Yuchen Pan, Zhifang Jia, Xinyi Yu, Haiyong Lv, Yangyu Zhang, Yanhua Wu, Jing Jiang   +6 more
doaj   +3 more sources

Hepatocellular carcinoma risk scores for non-viral liver disease: A systematic review and meta-analysis [PDF]

JHEP Reports
Background & Aims: Hepatocellular carcinoma (HCC) risk prediction models may provide a more personalised approach to surveillance for HCC among patients with cirrhosis. This systematic review aims to summarise the performance of HCC prediction models
Laura Burke, Alexander Hinkson, Vincent Haghnejad, Rebecca Jones, Richard Parker, Ian A. Rowe   +5 more
doaj   +2 more sources